Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Flexion Therapeutics Company Profile (NASDAQ:FLXN)

Consensus Ratings for Flexion Therapeutics (NASDAQ:FLXN) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $29.00 (134.06% upside)

Analysts' Ratings History for Flexion Therapeutics (NASDAQ:FLXN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/19/2014Janney Montgomery ScottInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Needham & Company LLCInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
3/10/2014BMO Capital MarketsInitiated CoverageOutperform$33.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Needham & Company LLCInitiated CoverageBuy$26.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2012 forward)